Literature DB >> 30834955

Brain regional volume estimations with NeuroQuant and FIRST: a study in patients with a clinically isolated syndrome.

Deborah Pareto1, Jaume Sastre-Garriga2, Manel Alberich3, Cristina Auger3, Mar Tintoré2, Xavier Montalban2, Àlex Rovira3.   

Abstract

PURPOSE: Brain volume estimates from magnetic resonance images (MRIs) are of great interest in multiple sclerosis, and several automated tools have been developed for this purpose. The goal of this study was to assess the agreement between two tools, NeuroQuant® (NQ) and FMRIB's Integrated Registration Segmentation Tool (FIRST), for estimating overall and regional brain volume in a cohort of patients with a clinically isolated syndrome (CIS). In addition, white matter lesion volume was estimated with NQ and the Lesion Segmentation Toolbox (LST).
METHODS: One hundred fifteen CIS patients were analysed. Structural images were acquired on a 3.0-T system. The volume agreement between methods (by estimation of the intraclass correlation coefficient) was calculated for the right and left thalamus, caudate, putamen, pallidum, hippocampus, and amygdala, as well as for the total intracranial volume and white matter lesion volume.
RESULTS: In general, the estimated volumes were larger by NQ than FIRST, except for the pallidum. Agreement was low (ICC < 0.40) for the smaller structures (amygdala and pallidum) and fair to good (ICC > 0.40) for the remaining ones. Agreement was fair for lesion volume (ICC = 0.61), with NQ estimates lower than LST.
CONCLUSIONS: Agreement between NQ and FIRST brain volume estimates depends on the size of the structure of interest, with larger volumes achieving better agreement. In addition, concordance between the two tools does seem to be dependent on the presence of brain lesions.

Entities:  

Keywords:  Brain lesion volume estimation; Brain volume estimation; Clinically isolated syndrome; Multiple sclerosis

Mesh:

Year:  2019        PMID: 30834955     DOI: 10.1007/s00234-019-02191-3

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  5 in total

1.  Hippocampal Sclerosis Detection with NeuroQuant Compared with Neuroradiologists.

Authors:  S Louis; M Morita-Sherman; S Jones; D Vegh; W Bingaman; I Blumcke; N Obuchowski; F Cendes; L Jehi
Journal:  AJNR Am J Neuroradiol       Date:  2020-03-26       Impact factor: 3.825

2.  Brain Atrophy in Relapsing Optic Neuritis Is Associated With Crion Phenotype.

Authors:  Laura Navarro Cantó; Sara Carratalá Boscá; Carmen Alcalá Vicente; Sara Gil-Perontín; Francisco Pérez-Miralles; Jessica Castillo Villalba; Laura Cubas Nuñez; Bonaventura Casanova Estruch
Journal:  Front Neurol       Date:  2019-11-01       Impact factor: 4.003

3.  LesionQuant for Assessment of MRI in Multiple Sclerosis-A Promising Supplement to the Visual Scan Inspection.

Authors:  Synne Brune; Einar A Høgestøl; Vanja Cengija; Pål Berg-Hansen; Piotr Sowa; Gro O Nygaard; Hanne F Harbo; Mona K Beyer
Journal:  Front Neurol       Date:  2020-12-11       Impact factor: 4.003

Review 4.  Updated Review of the Evidence Supporting the Medical and Legal Use of NeuroQuant® and NeuroGage® in Patients With Traumatic Brain Injury.

Authors:  David E Ross; John Seabaugh; Jan M Seabaugh; Justis Barcelona; Daniel Seabaugh; Katherine Wright; Lee Norwind; Zachary King; Travis J Graham; Joseph Baker; Tanner Lewis
Journal:  Front Hum Neurosci       Date:  2022-04-08       Impact factor: 3.473

Review 5.  Technical and clinical validation of commercial automated volumetric MRI tools for dementia diagnosis-a systematic review.

Authors:  Hugh G Pemberton; Lara A M Zaki; Olivia Goodkin; Ravi K Das; Rebecca M E Steketee; Frederik Barkhof; Meike W Vernooij
Journal:  Neuroradiology       Date:  2021-09-03       Impact factor: 2.804

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.